Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Promising initial results for Synvisc in osteoarthritis of the hip

July 13, 2000

Hydrazine-based inhibitors of TNF-alpha release described by Roche

July 11, 2000

D-Pharm reveals results with prodrug approach to NSAIDs

July 6, 2000

European investigators report immunomodulatory antiarthritic effects for HS-378

July 5, 2000

Compounds with utility for the treatment of cytokine-mediated disorders

July 3, 2000

New iNOS inhibitors claimed by AstraZeneca for use in inflammation and pain

June 30, 2000

E.U. approves Remicade for rheumatoid arthritis

June 30, 2000

Human parvovirus-containing vaccines for rheumatoid arthritis

June 28, 2000

New Pfizer compounds with selectivity for certain MMPs and TACE

June 28, 2000

Takeda's angiogenesis inhibitor TNP-470 shows additional potential in rheumatoid arthritis

June 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...